GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Sale Of Investment

Notable Labs (Notable Labs) Sale Of Investment : $ Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Sale Of Investment?

Notable Labs's sale of investment for the six months ended in Dec. 2023 was $0.00 Mil. It means Notable Labs gained $0.00 Mil from selling investments.

Compared with last quarter ($1.46 Mil in Dec. 2022 ), Notable Labs gained less money from selling investments in Dec. 2023 ($0.00 Mil).


Notable Labs Sale Of Investment Historical Data

The historical data trend for Notable Labs's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Sale Of Investment Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Sale Of Investment
20.09 1.46 -

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Sale Of Investment 20.09 1.46 -

Notable Labs Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.


Notable Labs Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Notable Labs's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.